Loss of KLF14 triggers centrosome amplification and tumorigenesis

  • Guangjian Fan
  • , Lianhui Sun
  • , Peipei Shan
  • , Xianying Zhang
  • , Jinliang Huan
  • , Xiaohong Zhang
  • , Dali Li
  • , Tingting Wang
  • , Tingting Wei
  • , Xiaohong Zhang
  • , Xiaoyang Gu
  • , Liangfang Yao
  • , Yang Xuan
  • , Zhaoyuan Hou
  • , Yongping Cui
  • , Liu Cao
  • , Xiaotao Li
  • , Shengping Zhang
  • , Chuangui Wang*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

Centrosome amplification is frequent in cancer, but the underlying mechanisms remain unclear. Here we report that disruption of the Kruppel-like factor 14 (KLF14) gene in mice causes centrosome amplification, aneuploidy and spontaneous tumorigenesis. Molecularly, KLF14 functions as a transcriptional repressor of Plk4, a polo-like kinase whose overexpression induces centrosome overduplication. Transient knockdown of KLF14 is sufficient to induce Plk4-directed centrosome amplification. Clinically, KLF14 transcription is significantly downregulated, whereas Plk4 transcription is upregulated in multiple types of cancers, and there exists an inverse correlation between KLF14 and Plk4 protein expression in human breast and colon cancers. Moreover, KLF14 depletion promotes AOM/DSS-induced colon tumorigenesis. Our findings reveal that KLF14 reduction serves as a mechanism leading to centrosome amplification and tumorigenesis. On the other hand, forced expression of KLF14 leads to mitotic catastrophe. Collectively, our findings identify KLF14 as a tumour suppressor and highlight its potential as biomarker and therapeutic target for cancer.

Original languageEnglish
Article number8450
JournalNature Communications
Volume6
DOIs
StatePublished - 6 Oct 2015

Fingerprint

Dive into the research topics of 'Loss of KLF14 triggers centrosome amplification and tumorigenesis'. Together they form a unique fingerprint.

Cite this